drugset / Trial / NCT01188317
A Study of Aleglitazar in Combination With Ibuprofen in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized, double-blind, placebo-controlled, parallel group study will investigate the safety and tolerability, and the effect of aleglitazar in combination with ibuprofen on renal function, renin-angiotensin system and pharmacokinetics in healthy volunteers. Volunteers will be randomized to receive daily doses of aleglitazar or placebo in combination with ibuprofen. The anticipated time on study drug is 5 weeks.
Timeline
- Start
- 2010-06
- Primary completion
- —
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen | Small molecule | — | — |
| Subject | aleglitazar | Small molecule | 150 ug | — |
Indications
No indication recorded.